×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
SalvaRx patently making progress | AIM:SALV
Proactive Investors
SalvaRx Group PLC (LON:SALV), a biotechnology company focused on immunotherapy for cancer, had some good news for shareholders on the US...
92 months ago
Jim Mellon-backed cancer drug company SalvaRx launches on Aim
The Telegraph
Failed Polish oil and gas investor 3Legs will relaunch on the junior market as a cancer drug company backed by multi-millionaire investor...
97 months ago
SalvaRx boss hails 'transformative' 2015 | AIM:SALV
Proactive Investors
SalvaRx PLC (LON:SALV) chief executive Ian Walters called 2015 a “transformative year” – one which the business evolved to focus on the life...
94 months ago